Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 12/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 1.00 |
| ▸ | SLC10A2 | Q12908 | 3/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 2/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 1/20 | 1.00 |
| ▸ | SLC10A1 | Q14973 | 6/20 | 0.89 |
| ▸ | VDR | P11473 | 1/20 | 0.79 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurochenodeoxycholate SCHEMBL9152921 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL4411471 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL13094131 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL12917602 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24001493 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL40763 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24435723 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL17641266 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24015433 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL17309129 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5971 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139227-A1 | ADIPOSE-DERIVED REGENERATIVE CELL PREPARATIONS | BLUE CELL THERAPEUTICS APS (DK) | 2026-05-21 | — | — | US | claimed |
| US-20260131089-A1 | DRUG DELIVERY DEVICES AND METHODS FOR ADMINISTERING SUBSTANCES TO A BODY CAVITY BY HETEROGENOUS AEROSOLIZATION FOR TREATMENT OF BINGE-EATING DISORDERS AND/OR OBESITY | APTARGROUP, INC. (US) | 2026-05-14 | — | — | US | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260062497-A1 | Pharmaceutical Formulation and Dosing Regimen for the Treatment of Amyotrophic Lateral Sclerosis | AL-S PHARMA AG (CH) | 2026-03-05 | — | — | US | claimed |
| EP-4262876-B1 | COVALENTLY MODIFIED ANTIGENS FOR IMPROVED IMMUNE RESPONSE AND/OR STABILITY | DEFENCE THERAPEUTICS INC (CA) | 2026-02-25 | — | — | EP | claimed |
| EP-4695613-A2 | METHODS OF MODIFYING NEURONS IN VIVO TO TREAT AND/OR PREVENT AMYOTROPHIC LATERAL SCLEROSIS (ALS) | Yale University (US) | 2026-02-18 | — | — | EP | claimed |
| US-12491325-B2 | Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity | APTARGROUP, INC. (US) | 2025-12-09 | — | — | US | claimed |
| US-20250302824-A1 | IN SITU READY-TO-USE INJECTION FORMULATIONS OF POSACONAZOLE FREE OF CYCLODEXTRIN AND ITS DERIVATIVES | Hefei Cosource Pharmaceuticals Co., Ltd (CN) | 2025-10-02 | — | — | US | claimed |
| EP-4608505-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS OF USE | Sanare Pharmaceuticals Corporation (US) | 2025-09-03 | — | — | EP | claimed |
| US-5324514-A | Digestive system disorders | DIGESTIVE CARE INC. (US) | 1994-06-28 | — | — | US | claimed |
| US-5302400-A | Blending pulverized enzymes and buffers, compacting, drying, coating with acid-resistant polymer | DIGESTIVE CARE INC. (US) | 1994-04-12 | — | — | US | claimed |
| EP-0576938-A1 | Composition of digestive enzymes and salts of bile acids and process for preparation thereof | DIGESTIVE CARE INC. (US) | 1994-01-05 | — | — | EP | claimed |
| EP-0574894-A1 | Composition of gastric acid - resistant microspheres containing buffered bile acids | DIGESTIVE CARE INC. (US) | 1993-12-22 | — | — | EP | claimed |
| US-5262172-A | Microencapsulation with carbonate, bicarbonate and amine buffers | DIGESTIVE CARE INC. (US) | 1993-11-16 | — | — | US | claimed |
| US-5260074-A | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof | DIGESTIVE CARE INC. (US) | 1993-11-09 | — | — | US | claimed |
| EP-0551451-A1 | N-ALKYL-TAUROURSODEOXYCHOLIC ACIDS AND THEIR THERAPEUTICALLY ACTIVE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PRODOTTI CHIMICI E ALIMENTARI SPA (IT) | 1993-07-21 | — | — | EP | claimed |
| EP-0513887-A1 | N-alkyltauroursodeoxycholic acids and their therapeutically active derivatives, a process for their preparation and pharmaceutical compositions containing them | PRODOTTI CHIMICI E ALIMENTARI SPA (IT) | 1992-11-19 | — | — | EP | claimed |
| WO-1992018524-A1 | N-ALKYL-TAUROURSODEOXYCHOLIC ACIDS AND THEIR THERAPEUTICALLY ACTIVE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PRODOTTI CHIMICI E ALIMENTARI S.P.A. (IT) | 1992-10-29 | — | — | WO | claimed |
| EP-0359058-A1 | 2-Hydoxy-N,N,N-trimethyl-ethanaminium salts of 5-beta-cholan-24-oic acid | Diamalt GmbH (DE) | 1990-03-21 | — | — | EP | claimed |